TFS Capital’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

TFS Capital’s Portfolio FRTX Stock Details FRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-73	Closed	-$243K	–	1160
2014 Q4	$243K	Sell	73 -134	-65%	-$475K	0.02%	779
2014 Q3	$729K	Sell	207 -166	-45%	-$645K	0.06%	471
2014 Q2	$1.43M	Sell	373 -270	-42%	-$1.02M	0.11%	286
2014 Q1	$2.61M	Buy	643 +218	+51%	+$973K	0.17%	161
2013 Q4	$1.58M	Buy	425 +420	+8,400%	+$1.59M	0.07%	385
2013 Q3	$18K	Sell	5 -129	-96%	-$968K	﹤0.01%	1406
2013 Q2	$1.32M	Buy	+134	New	+$1.48M	0.06%	488

Other funds holding FRTX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

SGAM

Smith Group Asset Management Dallas, Texas $1.96B AUM 43.61% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

TFS Capital's FRTX Position: Q1 2015 in Review

TFS Capital sold out of Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) in Q1 2015, closing a stake of 73 shares — an estimated $243K sold.

TFS Capital first reported a position in FRTX in Q2 2013 and held it in 7 quarters. The position peaked at $2.61M in Q1 2014. 60 funds tracked by Wall St. Rank hold FRTX as of Q1 2015.

TFS Capital reported no remaining Fresh Tracks Therapeutics, Inc. Common Stock position as of Q1 2015 after selling out during the quarter.
TFS Capital sold 73 Fresh Tracks Therapeutics, Inc. Common Stock shares in Q1 2015, an estimated $243K.
TFS Capital first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q2 2013 and held it in 7 quarters.
TFS Capital's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $2.61M in Q1 2014.
60 funds tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q1 2015.

Based on TFS Capital's 13F filing for Q1 2015, filed 29 Apr 2015.